| 000 | 01687 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250513195939.0 | ||
| 264 | 0 | _c20000113 | |
| 008 | 200001s 0 0 eng d | ||
| 022 | _a0091-6749 | ||
| 024 | 7 |
_a10.1016/s0091-6749(99)70012-6 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKemp, J P | |
| 245 | 0 | 0 |
_aA 1-year study of salmeterol powder on pulmonary function and hyperresponsiveness to methacholine. _h[electronic resource] |
| 260 |
_bThe Journal of allergy and clinical immunology _cDec 1999 |
||
| 300 |
_a1189-97 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 |
_aAdrenergic beta-Agonists _xadministration & dosage |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAlbuterol _xadministration & dosage |
| 650 | 0 | 4 |
_aAsthma _xdiagnosis |
| 650 | 0 | 4 | _aBronchial Provocation Tests |
| 650 | 0 | 4 |
_aBronchodilator Agents _xadministration & dosage |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPeak Expiratory Flow Rate _xdrug effects |
| 650 | 0 | 4 | _aRespiratory Function Tests |
| 650 | 0 | 4 | _aSalmeterol Xinafoate |
| 700 | 1 | _aDeGraff, A C | |
| 700 | 1 | _aPearlman, D S | |
| 700 | 1 | _aWang, Y | |
| 700 | 1 | _aArledge, T E | |
| 700 | 1 | _aWelch, M B | |
| 700 | 1 | _aO'Riordan, T G | |
| 700 | 1 | _aHerrle, M R | |
| 700 | 1 | _aStahl, E G | |
| 773 | 0 |
_tThe Journal of allergy and clinical immunology _gvol. 104 _gno. 6 _gp. 1189-97 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0091-6749(99)70012-6 _zAvailable from publisher's website |
| 999 |
_c10545158 _d10545158 |
||